GLO1
Basic information
Region (hg38): 6:38675925-38703145
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GLO1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 9 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 0 | 0 |
Variants in GLO1
This is a list of pathogenic ClinVar variants found in the GLO1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-38677376-C-A | not specified | Uncertain significance (Aug 02, 2021) | ||
6-38682074-A-C | not specified | Uncertain significance (Oct 26, 2022) | ||
6-38682074-A-G | not specified | Uncertain significance (Jul 12, 2023) | ||
6-38682106-C-T | Likely benign (Jul 19, 2018) | |||
6-38682852-T-G | Autism, susceptibility to, 1 | Uncertain significance (Dec 30, 2010) | ||
6-38684499-A-C | not specified | Uncertain significance (Jun 18, 2021) | ||
6-38702981-G-C | not specified | Uncertain significance (Feb 23, 2023) | ||
6-38703013-C-A | not specified | Uncertain significance (Mar 29, 2022) | ||
6-38703015-C-G | not specified | Uncertain significance (Aug 04, 2023) | ||
6-38703015-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
6-38703027-C-T | not specified | Uncertain significance (Nov 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GLO1 | protein_coding | protein_coding | ENST00000373365 | 6 | 27217 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.67e-7 | 0.336 | 125648 | 0 | 99 | 125747 | 0.000394 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.420 | 82 | 93.4 | 0.878 | 0.00000438 | 1205 |
Missense in Polyphen | 29 | 32.07 | 0.90426 | 411 | ||
Synonymous | -0.0825 | 34 | 33.4 | 1.02 | 0.00000156 | 322 |
Loss of Function | 0.419 | 10 | 11.5 | 0.867 | 7.47e-7 | 126 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00205 | 0.00191 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00185 | 0.00169 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000226 | 0.000220 |
Middle Eastern | 0.00185 | 0.00169 |
South Asian | 0.000231 | 0.000229 |
Other | 0.000333 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the conversion of hemimercaptal, formed from methylglyoxal and glutathione, to S-lactoylglutathione. Involved in the regulation of TNF-induced transcriptional activity of NF- kappa-B. Required for normal osteoclastogenesis. {ECO:0000269|PubMed:19199007, ECO:0000269|PubMed:23122816, ECO:0000269|PubMed:9705294}.;
- Pathway
- Pyruvate metabolism - Homo sapiens (human);Pyruvate Dehydrogenase Complex Deficiency;Primary hyperoxaluria II, PH2;Pyruvate kinase deficiency;Leigh Syndrome;Pyruvate Metabolism;Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency);Pyruvaldehyde Degradation;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism;methylglyoxal degradation I
(Consensus)
Recessive Scores
- pRec
- 0.906
Intolerance Scores
- loftool
- 0.821
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 49.76
Haploinsufficiency Scores
- pHI
- 0.350
- hipred
- N
- hipred_score
- 0.401
- ghis
- 0.616
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.969
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Glo1
- Phenotype
- homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- glo1
- Affected structure
- blood vessel
- Phenotype tag
- abnormal
- Phenotype quality
- increased branchiness
Gene ontology
- Biological process
- carbohydrate metabolic process;pyruvate metabolic process;regulation of transcription by RNA polymerase II;glutathione metabolic process;methylglyoxal metabolic process;osteoclast differentiation;negative regulation of apoptotic process
- Cellular component
- nucleus;cytoplasm;cytosol;plasma membrane;extracellular exosome
- Molecular function
- lactoylglutathione lyase activity;zinc ion binding